SEPP1 polymorphisms modulate serum glucose and lipid response to Brazil nut supplementation

European Journal of Nutrition
Janaina L S DonadioSilvia M F Cozzolino

Abstract

The consumption of Brazil nuts has been associated with benefits to lipid metabolism and reductions in total cholesterol and LDL concentrations. They are the richest natural source of selenium which has essential functions in human physiology. Genetic polymorphisms in Selenoprotein P could impair lipid and glucose metabolisms. The aim of this work was to verify the influence of polymorphisms in genes for selenoproteins on blood lipid levels after dietary supplementation with Brazil nuts in healthy adults. The study included 130 healthy volunteers selected at the University of São Paulo, Brazil. They were supplemented with one nut a day for 8 weeks, followed by 8 weeks without intervention. The following analyses were performed: anthropometric measurements, serum fasting glucose, lipid profile, C-reactive protein and plasma MDA levels. The volunteers were genotyped for SNPs rs1050450, rs3811699, rs1800699, rs713041, rs3877899, rs7579, rs34713741, and rs5845 in genes for selenoproteins. The concentrations of total cholesterol and fasting glucose levels decreased after 8 weeks of supplementation (p < 0.05). Glucose levels were modulated by rs3877899 in SEPP1, with significantly lower levels observed for individuals with the GA + A...Continue Reading

Associated Clinical Trials

References

May 31, 2003·Science·Gregory V KryukovVadim N Gladyshev
Nov 16, 2004·Trends in Cardiovascular Medicine·Bernd Moosmann, Christian Behl
Sep 6, 2005·The Journal of Nutrition·Janine Mukuddem-PetersenJohann C Jerling
Dec 17, 2005·American Journal of Epidemiology·Rui JiangR Graham Barr
Nov 28, 2006·The British Journal of Nutrition·Ramon SeguraEmilio Ros
Nov 28, 2006·International Journal of Food Sciences and Nutrition·E RyanN M O'Brien
Apr 19, 2007·The Journal of Biological Chemistry·Hema VuntaK Sandeep Prabhu
May 31, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Catherine MéplanJohn E Hesketh
Feb 9, 2008·The American Journal of Clinical Nutrition·Christine D ThomsonJennifer M Campbell
Feb 27, 2008·Archives of Internal Medicine·Joachim BleysEliseo Guallar
Mar 31, 2009·Biochimica Et Biophysica Acta·Lutz Schomburg, Ulrich Schweizer
Apr 7, 2009·Biochimica Et Biophysica Acta·Raymond F Burk, Kristina E Hill
Nov 3, 2010·Cell Metabolism·Hirofumi MisuShuichi Kaneko
May 18, 2011·Annals of Internal Medicine·Margaret P RaymanEliseo Guallar
Mar 3, 2012·Lancet·Margaret P Rayman
Nov 6, 2012·Journal of Molecular Endocrinology·Holger SteinbrennerSven Schinner
Jul 11, 2013·Journal of Nutrition and Metabolism·Elisângela ColpoJoão Batista Teixeira da Rocha
Nov 22, 2013·The New England Journal of Medicine·Ying BaoCharles S Fuchs
Sep 2, 2014·The Journal of Investigative Dermatology·Heidy SierraMilind Rajadhyaksha

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.